Continuous combined hormone replacement therapy with 1 mg 17beta-oestradiol and 5 mg dydrogesterone (Femoston-conti): endometrial safety and bleeding profile.

Source:http://linkedlifedata.com/resource/pubmed/id/16043317

Maturitas 2006 Feb 20 53 3 299-305

Download in:

View as

General Info

PMID
16043317